Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: CMS rolls out an AI-enabled prior authorization program in six states to curb “wasteful” device use, and adds reimbursement support for patients to upgrade diabetes devices; FDA publishes updated cybersecurity guide; South Korea revises its innovative device guidance; the UK plans funding guarantees for medtech; and more global policy updates.
Approxima aims to treat the root cause, not just the valvular symptoms, of tricuspid regurgitation, with a novel minimally invasive treatment.
The African Medicines Agency launches. Excerpted from Pathways’ Picks May 28: Global Picks, FDA Guidance Docs, MDUFA Support, and More.